Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 22

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Growth hormone treatment of adolescents with growth hormone deficiency (GHD) during the transition period: results of a survey among adult and paediatric endocrinologists from Italy. Endorsed by SIEDP/ISPED, AME, SIE, SIMA

Aimaretti, G., Attanasio, R., Cannavò, S., Nicoletti, M. C., Castello, R., Di Somma, C., Garofalo, P., Iughetti, L., Loche, S., Maghnie, M., Mazzanti, L., Saggese, G., Salerno, M., Tonini, G., Toscano, V., Zucchini, S., Cappa, M.·2015·Journal of Endocrinological Investigation

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s40618-014-0201-7

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 48

  1. Rosenfeld RG, Nicodemus BC (2003) The transition from adolescence to adult life: physiology of the ‘transition’ phase and its evolutionary basis. Horm Res 60(Suppl 1):74–77 · DOI
  2. Filipsson Nyström H, Barbosa EJ, Nilsson AG et al (2012) Discontinuing long-term GH replacement therapy–a randomized, placebo-controlled crossover trial in adult GH deficiency. J Clin Endocrinol Metab 97:3185–3195 · DOI
  3. Capalbo D, Lo Vecchio A, Farina V et al (2009) Subtle alterations of cardiac performance in children with growth hormone deficiency: results of a two-year prospective, case-control study. J Clin Endocrinol Metab 94:3347–3355 · DOI
  4. Colao A, Di Somma C, Salerno M, Spinelli L, Orio F, Lombardi G (2002) The cardiovascular risk of GH-deficient adolescents. J Clin Endocrinol Metab 87:3650–3655 · DOI
  5. Hulthén L, Bengtsson BA, Sunnerhagen KS et al (2001) GH is needed for the maturation of muscle mass and strength in adolescents. J Clin Endocrinol Metab 86:4765–4770 · DOI
  6. Klefter O, Feldt-Rasmussen U (2009) Is increase in bone mineral content caused by increase in skeletal muscle mass/strength in adult patients with GH-treated GH deficiency? A systematic literature analysis. Eur J Endocrinol 161:213–221 · DOI
  7. Johannsson G, Albertsson-Wikland K, Bengtsson BA (1999) Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children. J Clin Endocrinol Metab 84:4516–4524
  8. Dommergues JP, Alvin P (2003) Transition from paediatric to adult care in severe chronic diseases in children. Arch Pediatr 10:295–299 · DOI
  9. Blum RW (1993) Transition from child-centered to adult health care: systems for adolescents with chronic conditions. J Adolesc Health 14:570–576 · DOI · Paper page
  10. Cacciari E, Tassoni P, Parisi G et al (1992) Pitfalls in diagnosing impaired growth hormone (GH) secretion: retesting after replacement therapy of 63 patients defined as GH deficient. J Clin Endocrinol Metab 74:1284–1289
  11. Cacciari E, Tassoni P, Cicognani A et al (1994) Value and limits of pharmacological and physiological tests to diagnose growth hormone (GH) deficiency and predict therapy response: first and second retesting during replacement therapy of patients defined as GH deficient. J Clin Endocrinol Metab 79:1663–1669
  12. Corneli G, Di Somma C, Prodam F et al (2007) Cut-off limits of the GH response to GHRH plus arginine test and IGF-I levels for the diagnosis of GH deficiency in late adolescents and young adults. Eur J Endocrinol 157:701–708 · DOI
  13. De Boer H, Van Der Veen EA (1997) Why retest young adults with childhood-onset growth hormone deficiency? J Clin Endocrinol Metab 82:2032–2036 · DOI
  14. Attanasio AF, Shalet SM (2007) Growth hormone and the transition from puberty into adulthood. Endocrinol Metab Clin North Am 36:187–201 · DOI
  15. Clayton P, Gleeson H, Monson J et al (2007) Growth hormone replacement throughout life: Insights into age-related responses to treatment. Growth Horm IGF Res 17:369–382 · DOI
  16. Elbornsson M, Götherström G, Bosæus I et al (2012) Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency. Eur J Endocrinol 166(5):787–795 · DOI
  17. Cook DM, Yuen KC et al (2009) American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients—2009 update: executive summary of recommendations. Endocr Pract 15:580–586 · DOI
  18. Cook DM, Rose SR (2012) A review of guidelines for use of growth hormone in pediatric and transition patients. Pituitary 15:301–310 · DOI
  19. Growth Hormone Research Society (2000) Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab 85:3990–3993
  20. Ho KK (2007) GH Deficiency Consensus Workshop Participants (2007) Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol 157:695–700 · DOI · Paper page
  21. Shea Chamberlain, Levy RA (2012) Transition care of patients with growth hormone deficiency from pediatric endocrinologists to adult endocrinologists. Endocr Pract 18:256–268 · DOI
  22. Norman Dalkey NC, Helmer O (1963) An experimental application of the Delphi method to the use of experts. Manag Sci 9:458–467 · DOI · Paper page
  23. Brown BB (1968) Delphi process: a methodology used for the elicitation of opinions of experts. RAND Corporation, Santa Monica (P-3925)
  24. Radetti G, Di Iorgi N, Paganini C et al (2007) The advantage of measuring spontaneous growth hormone (GH) secretion compared with the insulin tolerance test in the diagnosis of GH deficiency in young adults. Clin Endocrinol (Oxf) 67:78–84 · DOI
  25. Secco A, di Iorgi N, Napoli F et al (2009) Reassessment of the growth hormone status in young adults with childhood-onset growth hormone deficiency: reappraisal of insulin tolerance testing. J Clin Endocrinol Metab 94:4195–4204 · DOI
  26. Styne DM (2003) A practical approach to the diagnosis of growth hormone (GH) deficiency in patients transitioning to adulthood using GH stimulation testing. J Pediatr Endocrinol Metab 16:637–643
  27. Gasco V, Corneli G, Beccuti G et al (2008) Retesting the childhood-onset GH-deficient patient. Eur J Endocrinol 159(Suppl 1):S45–S52 · DOI
  28. Maghnie M, Strigazzi C, Tinelli C et al (1999) Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults. J Clin Endocrinol Metab 84:1324–1328 · DOI
  29. Maghnie M, Salati B, Bianchi S et al (2001) Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone plus arginine in children and adults with congenital hypopituitarism. J Clin Endocrinol Metab 86:1574–1579
  30. Juul A, Kastrup KW, Pedersen SA, Skakkebaek NE (1997) Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGFI) and IGF-binding protein-3. J Clin Endocrinol Metab 82:1195–1201
  31. Attanasio AF, Howell S, Bates PC et al (2002) Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severely GH deficient (GHD) patients after childhood GH treatment: a comparison with adult onset GHD patients. J Clin Endocrinol Metab 87:3368–3372 · DOI
  32. Attanasio AF, Lamberts SWJ, Matranga AMC et al (1997) Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. J Clin Endocrinol Metab 82:82–88
  33. Capaldo B, Patti L, Oliviero U et al (1997) Increased arterial intima-media thickness in childhood-onset growth hormone deficiency. J Clin Endocrinol Metab 82:1378–1381 · DOI
  34. Lanes R, Soros A, Flores K et al (2005) Endothelial function, carotid artery intima-media thickness, epicardial adipose tissue, and left ventricular mass and function in growth hormone-deficient adolescents: apparent effects of growth hormone treatment on these parameters. J Clin Endocrinol Metab 90:3978–3982 · DOI
  35. Attanasio AF, Shavrikova E, Blum WF et al (2004) Continued growth hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patients. Hypopituitary Developmental Outcome Study Group. J Clin Endocrinol Metab 89:4857–4862 · DOI
  36. Geffner ME (2009) Growth hormone replacement therapy: transition from adolescence to adulthood. J Clin Res Pediatr Endocrinol 1:205–208 · DOI
  37. Mauras N, Pescovitz OH, Allada V et al (2005) Limited efficacy of growth hormone (GH) during transition of GH-deficient patients from adolescence to adulthood: a phase III multicenter, double-blind, randomized two-year trial. J Clin Endocrinol Metab 90:3946–3955 · DOI
  38. Cook DM (2004) Growth hormone and estrogen: a clinician’s approach. J Pediatr Endocrinol Metab 17(Suppl 4):1273–1276
  39. Phelan N, Conway SH, Llahana S, Conway GS (2012) Quantification of the adverse effect of ethinylestradiol containing oral contraceptive pills when used in conjunction with growth hormone replacement in routine practice. Clin Endocrinol (Oxf) 76:729–733 · DOI
  40. Bonjour JP, Theintz G, Buchs B et al (1991) Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab 73:555–563 · DOI · Paper page
  41. Colao A, Di Somma C, Rota F et al (2005) Common carotid intima-media thickness in growth hormone (GH)-deficient adolescents: a prospective study after GH withdrawal and restarting GH replacement. J Clin Endocrinol Metab 90:2659–2665 · DOI
  42. Cuneo RC, Salomon F, Watts GF et al (1993) Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency. Metabolism 42:1519–1523 · DOI · Paper page
  43. Fideleff HL, Boquete HR, Stalldecker G et al (2008) Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients. Growth Horm IGF Res 18:318–324 · DOI
  44. Yuen KC, Biller BM, Molitch ME, Cook DM (2009) Clinical review: Is lack of recombinant growth hormone (GH)-releasing hormone in the United States a setback or time to consider glucagon testing for adult GH deficiency? J Clin Endocrinol Metab 94:2702–2707 · DOI
  45. Koranyi J, Svensson J, Götherström G et al (2001) Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study. J Clin Endocrinol Metab 86:4693–4699 · DOI
  46. Møller N, Jørgensen JO (2009) Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 30:152–177 · DOI · Paper page
  47. Magon N, Singh S, Saxena A, Sahay R (2011) Growth hormone in male infertility. Indian J Endocrinol Metab 15(Suppl 3):S248–S249 · DOI
  48. Conway GS, Szarras-Czapnik M, Racz K et al (2009) Treatment for 24 months with recombinant human GH has a beneficial effect on bone mineral density in young adults with childhood-onset GH deficiency. Eur J Endocrinol 160:899–907 · DOI

Cited by

Metadata

Authors
Aimaretti, G., Attanasio, R., Cannavò, S., Nicoletti, M. C., Castello, R., Di Somma, C., Garofalo, P., Iughetti, L., Loche, S., Maghnie, M., Mazzanti, L., Saggese, G., Salerno, M., Tonini, G., Toscano, V., Zucchini, S., & Cappa, M.
Venue
Journal of Endocrinological Investigation
Published
2014-11-02
Volume
38
Issue
3
Pages
377-382
ISSN
1720-8386
Cited by
22
References
4
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.